Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

UCB Data Shows Comparable Performance of Clones Cultured in ambr and 100L Bioreactors

Published: Thursday, April 11, 2013
Last Updated: Thursday, April 11, 2013
Bookmark and Share
Indicating TAP Biosystems’ micro bioreactor is a realistic scale-down model for cell line selection.

TAP Biosystems has announced that new data presented at a Cell Line Development and Engineering meeting by scientists at major European biopharmaceutical firm, UCB has shown that the micro-scale bioreactor system (ambr™) is equivalent in performance to a 100L bioreactor.

This indicates that ambr is a realistic scale-down model and can be used to improve cell line selection processes.

Scientists at UCB used the ambr system to culture five different protein expressing CHO cell lines. One of the five cell lines was also cultured under identical process conditions in 100L Applikon stirred tank bioreactors.

Their results showed that cultures grown in ambr were comparable to those grown in a 100L bioreactor in terms of growth, productivity and protein product quality.

The UCB scientists concluded that using ambr it was possible to test 24 clones in parallel, with results representative of the larger scale. This enables more cell lines to be evaluated in a shorter time, thus increasing the likelihood of selecting higher yielding clones.

Dr Barney Zoro, ambr Product Manager at TAP Biosystems concluded: “The data from UCB is very exciting because it shows that the 15mL ambr micro bioreactor is equivalent in performance to 100L bioreactors, allowing UCB’s scientists to reduce time lines for the cell line selection workflow, with confidence in scalability of the results. So it is now possible and time efficient, to evaluate many more lines for clone selection and this study confirms that using ambr as a scale-down model will provide scientists with a significant benefit when developing antibody and other protein based therapeutics.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors
Presents validation data for improving media screening and process optimization.
Friday, February 14, 2014
Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos